Healthcare - Biotechnology - NASDAQ - US
$ 3.38
2.42 %
$ 3.53 M
Market Cap
-0.23
P/E
INCOME STATEMENT
0
REVENUE
-16 M
OPERATING INCOME
-15.5 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Pasithea Therapeutics Corp.
| Revenue | 0 |
| Cost Of Revenue | 648 K |
| Gross Profit | -648 K |
| Operating Expenses | 16 M |
| Operating Income | -16 M |
| Other Expenses | -472 K |
| Net Income | -15.5 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|
| REVENUE | ||||
| Revenue | 0 | 0.5 | 15.1 K | 0 |
| GROSS PROFIT | ||||
| Cost Of Revenue | 0.6 | 0.1 | 17.3 K | 0 |
| Gross Profit | (0.6) | 0.4 | 2.21 K | 0 |
| OPERATING INCOME | ||||
| Operating Expenses | 16.0 | 15.2 | 4.5 | 41 K |
| Selling, General and Administrative Expenses | 7.9 | 12.5 | 4.5 | 41 K |
| Research and Development Expenses | 8.1 | 2.7 | 0 | 0 |
| Operating Income | (16.0) | (14.8) | (4.5) | 41 K |
| PRE-TAX INCOME | ||||
| Interest Income Expense | 0 | 102 | 508 | 0 |
| Total Other Income | 0.5 | 0.9 | 2.3 | 4 |
| Pre-Tax Income | (15.5) | (13.9) | (2.2) | 41 K |
| NET INCOME | ||||
| Tax Provision | 0 | (0.9) | 508 | 61.5 K |
| Net Income | (16.0) | (13.1) | (2.2) | 41 K |
| EPS | 12.7 | 10.3 | 1.89 | 0.0595 |